Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Millipore Expands Drug Discovery and Development Services with BioAnaLab Acquisition

Published: Tuesday, August 11, 2009
Last Updated: Tuesday, August 11, 2009
Bookmark and Share
Acquisition extends Millipore’s biopharmaceutical services offering to European market.

Millipore Corporation has announced it has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines.

The transaction enables Millipore to expand its biopharmaceutical services business into Europe and further strengthens its position as a preferred outsource partner to biopharmaceutical companies.

“As an increasing number of biologics enter the pipeline, companies are leveraging Millipore’s ligand binding assay expertise to help them evaluate the efficacy of these drugs and achieve regulatory compliance,” said Jonathan DiVincenzo, President of Millipore’s Bioscience Division.

“Our acquisition of BioAnaLab will allow us to build on our reputation as a trusted outsource partner in North America by establishing a presence in the fast-growing European biotech market. BioAnaLab will add cGMP support testing capabilities to our portfolio, a solid customer base, and a team of highly talented services professionals with expertise in emerging scientific disciplines,” DiVincenzo continued.

Based in Oxford, United Kingdom, BioAnaLab was spun out of the University of Oxford in 2002 to meet the requirements of the biopharmaceutical industry. The Company helps its customers better understand the safety and efficacy of biologic drugs and vaccines by providing a broad range of services to assist with evaluating and advancing these therapeutics from the drug development pipeline to the market.

Services offered by BioAnaLab include assay transfer/development, validation & sample analysis, pharmacokinetics/ toxicokinetics, immunogenicity, biological potency, and vaccine services. Millipore will bring substantial expertise in biomarker analytical services to strengthen BioAnaLab’s current offering in that area.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cellular Reprogramming – What the Future Holds
Advancements in cellular reprogramming are coming at a furious pace. Along with these scientific breakthroughs come new opportunities for the development of therapeutics, disease modeling, drug screening, and new pathways to personalized medicine.
Friday, July 23, 2010
Millipore Opens new Bioprocess Manufacturing Facility in Massachusetts
New facility will produce company’s Mobius® single-use product line used for biopharmaceutical manufacturing technologies.
Wednesday, June 10, 2009
Millipore and UMass Lowell Dedicate the Millipore Process Development Laboratory
Millipore announced the opening of the Millipore Corporation Process Development Laboratory in partnership with the university.
Friday, April 10, 2009
Millipore Announces Technology Acquisition to Strengthen Drug Discovery Product Offering
The purchase of Epitome Biosystems’ EpiTag™ technology assets will accelerate development of multiplex immunoassays for cell signaling.
Monday, March 02, 2009
Millipore Extends Exclusive License Agreement with University of Dundee
The ongoing collaboration will bring novel cell signaling tools and services to life science researchers worldwide.
Friday, October 10, 2008
ReNcell® VM Neural Stem Cell Line Models Parkinson’s Disease
Milipore announces the publication of a new discovery derived from its ReNcell VM neural stem cell line.
Tuesday, July 22, 2008
Millipore Unveils Expanded Drug Discovery Development Facility
The $3.4 million expansion will enable Millipore to keep pace with the growth of its worldwide drug discovery and development business.
Monday, June 30, 2008
Millipore Launches Progenitor Cell-Enriched Primary Human Epithelial Cell Cultures
According to Company, these primary cell cultures are designed to provide an enriched population of progenitor cells from skin, cornea, and bladder epithelia.
Friday, April 18, 2008
Millipore Launches Antibody Learning Center
The web tool is designed for navigating company’s antibody portfolio and planning efficient workflows for immunodetection in protein research.
Wednesday, April 16, 2008
Millipore Corporation and Novozymes Form Strategic Alliance to Supply Animal-Free Cell Culture Supplements for Bioprocessing
Alliance will accelerate launch of new animal-free supplements and provide customers with a source of high performance cell culture products.
Tuesday, December 18, 2007
Frost & Sullivan Commends Millipore’s Success in Developing Mammalian Gene Expression UCOE Technology
Millipore announced to be the recipient of the 2007 Frost & Sullivan Technology Innovation of the Year Award in the U.S. Drug Discovery Technologies market.
Monday, December 10, 2007
Millipore Announces Stem Cell Tested Initiative
Millipore’s Stericup with Express PLUS membrane is the first available under this initiative.
Wednesday, December 05, 2007
Millipore Launches new Website
Improved functions include product information, ordering and support.
Wednesday, October 31, 2007
Millipore Corporation Announces new ReNcell® Data from Collaboration with ReNeuron
Millipore releases new data concerning its ReNcell neural stem cell lines at the ISSCR meeting in Cairns, Australia on June 20, 2007.
Thursday, June 21, 2007
Millipore Announces Kinase Screening Agreement with Johnson & Johnson Pharmaceutical Research & Development
J&JPRD to supply potential protein kinase inhibitors for kinase selectivity profiling against Millipore's panel of 252 protein and lipid kinases.
Wednesday, January 17, 2007
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Protein Boosts Rice Yield by 54%
Over-expression of a natural protein in rice plants led to a 54% increase in crop yield and 40% increase in nitrogen-use efficiency.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Soil Nitrogen Age Important for Precision Agriculture
Calculating the age of nitrogen in corn and soybean fields could lead to improved fertilizer application techniques.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!